Patient	O
Preferences	O
in	O
Treatment	B:C0087111
Choices	O
for	O
Early	O
-	O
Stage	O
Lung	O
Cancer	I:C0242379
.	O

Patient	O
Preferences	O
in	O
Treatment	O
Choices	O
for	O
Early	O
-	O
Stage	O
Lung	B:C0242379
Cancer	I:C0242379
.	O

Decision	B:C0011109
-	I:C0011109
making	I:C0011109
for	O
lung	O
cancer	I:C0242379
treatment	O
can	O
be	O
complex	O
because	O
it	O
involves	O
both	O
provider	O
recommendations	O
based	O
on	O
the	O
patient	O
's	O
clinical	O
condition	O
and	O
patient	O
preferences	O
.	O

Decision	O
-	I:C0011109
making	I:C0011109
for	O
lung	B:C0242379
cancer	I:C0242379
treatment	O
can	O
be	O
complex	O
because	O
it	O
involves	O
both	O
provider	O
recommendations	O
based	O
on	O
the	O
patient	O
's	O
clinical	O
condition	O
and	O
patient	O
preferences	O
.	O

Decision	O
-	I:C0011109
making	I:C0011109
for	O
lung	O
cancer	I:C0242379
treatment	B:C0087111
can	O
be	O
complex	O
because	O
it	O
involves	O
both	O
provider	O
recommendations	O
based	O
on	O
the	O
patient	O
's	O
clinical	O
condition	O
and	O
patient	O
preferences	O
.	O

Decision	O
-	I:C0011109
making	I:C0011109
for	O
lung	O
cancer	I:C0242379
treatment	O
can	O
be	O
complex	O
because	O
it	O
involves	O
both	O
provider	B:C0031831
recommendations	O
based	O
on	O
the	O
patient	O
's	O
clinical	O
condition	O
and	O
patient	O
preferences	O
.	O

This	O
study	B:C2603343
describes	O
the	O
relative	O
importance	O
of	O
several	O
considerations	O
in	O
lung	O
cancer	I:C0242379
treatment	O
from	O
the	O
patient	O
's	O
perspective	O
.	O

This	O
study	O
describes	O
the	O
relative	O
importance	O
of	O
several	O
considerations	B:C0518609
in	O
lung	O
cancer	I:C0242379
treatment	O
from	O
the	O
patient	O
's	O
perspective	O
.	O

This	O
study	O
describes	O
the	O
relative	O
importance	O
of	O
several	O
considerations	O
in	O
lung	B:C0242379
cancer	I:C0242379
treatment	O
from	O
the	O
patient	O
's	O
perspective	O
.	O

This	O
study	O
describes	O
the	O
relative	O
importance	O
of	O
several	O
considerations	O
in	O
lung	O
cancer	I:C0242379
treatment	B:C0087111
from	O
the	O
patient	O
's	O
perspective	O
.	O

A	O
conjoint	B:C0681814
preference	I:C0681814
experiment	I:C0681814
began	O
by	O
asking	O
respondents	O
to	O
imagine	O
that	O
they	O
had	O
just	O
been	O
diagnosed	O
with	O
lung	O
cancer	I:C0242379
.	O

A	O
conjoint	O
preference	I:C0681814
experiment	I:C0681814
began	O
by	O
asking	O
respondents	B:C0282122
to	O
imagine	O
that	O
they	O
had	O
just	O
been	O
diagnosed	O
with	O
lung	O
cancer	I:C0242379
.	O

A	O
conjoint	O
preference	I:C0681814
experiment	I:C0681814
began	O
by	O
asking	O
respondents	O
to	O
imagine	O
that	O
they	O
had	O
just	O
been	O
diagnosed	B:C0011900
with	O
lung	O
cancer	I:C0242379
.	O

A	O
conjoint	O
preference	I:C0681814
experiment	I:C0681814
began	O
by	O
asking	O
respondents	O
to	O
imagine	O
that	O
they	O
had	O
just	O
been	O
diagnosed	O
with	O
lung	B:C0242379
cancer	I:C0242379
.	O

Respondents	B:C0282122
then	O
chose	O
among	O
procedures	O
that	O
differed	O
regarding	O
treatment	O
modalities	O
,	O
the	O
potential	O
for	O
treatment	O
-	O
related	O
complications	O
,	O
the	O
likelihood	O
of	O
recurrence	O
,	O
provider	O
case	O
volume	O
,	O
and	O
distance	O
needed	O
to	O
travel	O
for	O
treatment	O
.	O

Respondents	O
then	O
chose	O
among	O
procedures	B:C0087111
that	O
differed	O
regarding	O
treatment	O
modalities	O
,	O
the	O
potential	O
for	O
treatment	O
-	O
related	O
complications	O
,	O
the	O
likelihood	O
of	O
recurrence	O
,	O
provider	O
case	O
volume	O
,	O
and	O
distance	O
needed	O
to	O
travel	O
for	O
treatment	O
.	O

Respondents	O
then	O
chose	O
among	O
procedures	O
that	O
differed	O
regarding	O
treatment	B:C0087111
modalities	O
,	O
the	O
potential	O
for	O
treatment	O
-	O
related	O
complications	O
,	O
the	O
likelihood	O
of	O
recurrence	O
,	O
provider	O
case	O
volume	O
,	O
and	O
distance	O
needed	O
to	O
travel	O
for	O
treatment	O
.	O

Respondents	O
then	O
chose	O
among	O
procedures	O
that	O
differed	O
regarding	O
treatment	O
modalities	O
,	O
the	O
potential	O
for	O
treatment	B:C0087111
-	O
related	O
complications	O
,	O
the	O
likelihood	O
of	O
recurrence	O
,	O
provider	O
case	O
volume	O
,	O
and	O
distance	O
needed	O
to	O
travel	O
for	O
treatment	O
.	O

Respondents	O
then	O
chose	O
among	O
procedures	O
that	O
differed	O
regarding	O
treatment	O
modalities	O
,	O
the	O
potential	O
for	O
treatment	O
-	O
related	O
complications	B:C0009566
,	O
the	O
likelihood	O
of	O
recurrence	O
,	O
provider	O
case	O
volume	O
,	O
and	O
distance	O
needed	O
to	O
travel	O
for	O
treatment	O
.	O

Respondents	O
then	O
chose	O
among	O
procedures	O
that	O
differed	O
regarding	O
treatment	O
modalities	O
,	O
the	O
potential	O
for	O
treatment	O
-	O
related	O
complications	O
,	O
the	O
likelihood	O
of	O
recurrence	O
,	O
provider	B:C0031831
case	O
volume	O
,	O
and	O
distance	O
needed	O
to	O
travel	O
for	O
treatment	O
.	O

Respondents	O
then	O
chose	O
among	O
procedures	O
that	O
differed	O
regarding	O
treatment	O
modalities	O
,	O
the	O
potential	O
for	O
treatment	O
-	O
related	O
complications	O
,	O
the	O
likelihood	O
of	O
recurrence	O
,	O
provider	O
case	O
volume	O
,	O
and	O
distance	O
needed	O
to	O
travel	O
for	O
treatment	B:C0087111
.	O

Conjoint	B:C0681814
analysis	I:C0681814
derived	O
relative	O
weights	O
for	O
these	O
attributes	O
.	O

A	O
total	O
of	O
225	O
responses	B:C1706817
were	O
analyzed	O
.	O

A	O
total	O
of	O
225	O
responses	O
were	O
analyzed	B:C0936012
.	O

Respondents	B:C0282122
were	O
most	O
willing	O
to	O
accept	O
minimally	O
invasive	O
operations	I:C4048276
for	O
treatment	O
of	O
their	O
hypothetical	O
lung	O
cancer	I:C0242379
,	O
followed	O
by	O
stereotactic	O
body	I:C3896609
radiation	I:C3896609
therapy	I:C3896609
(	O
stereotactic	O
body	I:C3896609
radiation	I:C3896609
therapy	I:C3896609
)	O
;	O
they	O
were	O
least	O
willing	O
to	O
accept	O
thoracotomy	O
.	O

Respondents	O
were	O
most	O
willing	O
to	O
accept	O
minimally	O
invasive	B:C4048276
operations	I:C4048276
for	O
treatment	O
of	O
their	O
hypothetical	O
lung	O
cancer	I:C0242379
,	O
followed	O
by	O
stereotactic	O
body	I:C3896609
radiation	I:C3896609
therapy	I:C3896609
(	O
stereotactic	O
body	I:C3896609
radiation	I:C3896609
therapy	I:C3896609
)	O
;	O
they	O
were	O
least	O
willing	O
to	O
accept	O
thoracotomy	O
.	O

Respondents	O
were	O
most	O
willing	O
to	O
accept	O
minimally	O
invasive	O
operations	I:C4048276
for	O
treatment	B:C0087111
of	O
their	O
hypothetical	O
lung	O
cancer	I:C0242379
,	O
followed	O
by	O
stereotactic	O
body	I:C3896609
radiation	I:C3896609
therapy	I:C3896609
(	O
stereotactic	O
body	I:C3896609
radiation	I:C3896609
therapy	I:C3896609
)	O
;	O
they	O
were	O
least	O
willing	O
to	O
accept	O
thoracotomy	O
.	O

Respondents	O
were	O
most	O
willing	O
to	O
accept	O
minimally	O
invasive	O
operations	I:C4048276
for	O
treatment	O
of	O
their	O
hypothetical	O
lung	B:C0242379
cancer	I:C0242379
,	O
followed	O
by	O
stereotactic	O
body	I:C3896609
radiation	I:C3896609
therapy	I:C3896609
(	O
stereotactic	O
body	I:C3896609
radiation	I:C3896609
therapy	I:C3896609
)	O
;	O
they	O
were	O
least	O
willing	O
to	O
accept	O
thoracotomy	O
.	O

Respondents	O
were	O
most	O
willing	O
to	O
accept	O
minimally	O
invasive	O
operations	I:C4048276
for	O
treatment	O
of	O
their	O
hypothetical	O
lung	O
cancer	I:C0242379
,	O
followed	O
by	O
stereotactic	B:C3896609
body	I:C3896609
radiation	I:C3896609
therapy	I:C3896609
(	O
stereotactic	O
body	I:C3896609
radiation	I:C3896609
therapy	I:C3896609
)	O
;	O
they	O
were	O
least	O
willing	O
to	O
accept	O
thoracotomy	O
.	O

Respondents	O
were	O
most	O
willing	O
to	O
accept	O
minimally	O
invasive	O
operations	I:C4048276
for	O
treatment	O
of	O
their	O
hypothetical	O
lung	O
cancer	I:C0242379
,	O
followed	O
by	O
stereotactic	O
body	I:C3896609
radiation	I:C3896609
therapy	I:C3896609
(	O
stereotactic	B:C3896609
body	I:C3896609
radiation	I:C3896609
therapy	I:C3896609
)	O
;	O
they	O
were	O
least	O
willing	O
to	O
accept	O
thoracotomy	O
.	O

Respondents	O
were	O
most	O
willing	O
to	O
accept	O
minimally	O
invasive	O
operations	I:C4048276
for	O
treatment	O
of	O
their	O
hypothetical	O
lung	O
cancer	I:C0242379
,	O
followed	O
by	O
stereotactic	O
body	I:C3896609
radiation	I:C3896609
therapy	I:C3896609
(	O
stereotactic	O
body	I:C3896609
radiation	I:C3896609
therapy	I:C3896609
)	O
;	O
they	O
were	O
least	O
willing	O
to	O
accept	O
thoracotomy	B:C0039991
.	O

Treatment	B:C0087111
type	O
and	O
risk	O
of	O
recurrence	O
were	O
the	O
most	O
important	O
attributes	O
from	O
the	O
conjoint	O
experiment	I:C0681814
(	O
each	O
with	O
a	O
relative	O
weight	O
of	O
0.23	O
)	O
,	O
followed	O
by	O
provider	O
volume	O
(	O
relative	O
weight	O
of	O
0.21	O
)	O
,	O
risk	O
of	O
major	O
complications	O
(	O
relative	O
weight	O
of	O
0.18	O
)	O
,	O
and	O
distance	O
needed	O
to	O
travel	O
for	O
treatment	O
(	O
relative	O
weight	O
of	O
0.15	O
)	O
.	O

Treatment	O
type	O
and	O
risk	O
of	O
recurrence	O
were	O
the	O
most	O
important	O
attributes	O
from	O
the	O
conjoint	B:C0681814
experiment	I:C0681814
(	O
each	O
with	O
a	O
relative	O
weight	O
of	O
0.23	O
)	O
,	O
followed	O
by	O
provider	O
volume	O
(	O
relative	O
weight	O
of	O
0.21	O
)	O
,	O
risk	O
of	O
major	O
complications	O
(	O
relative	O
weight	O
of	O
0.18	O
)	O
,	O
and	O
distance	O
needed	O
to	O
travel	O
for	O
treatment	O
(	O
relative	O
weight	O
of	O
0.15	O
)	O
.	O

Treatment	O
type	O
and	O
risk	O
of	O
recurrence	O
were	O
the	O
most	O
important	O
attributes	O
from	O
the	O
conjoint	O
experiment	I:C0681814
(	O
each	O
with	O
a	O
relative	O
weight	O
of	O
0.23	O
)	O
,	O
followed	O
by	O
provider	B:C0031831
volume	O
(	O
relative	O
weight	O
of	O
0.21	O
)	O
,	O
risk	O
of	O
major	O
complications	O
(	O
relative	O
weight	O
of	O
0.18	O
)	O
,	O
and	O
distance	O
needed	O
to	O
travel	O
for	O
treatment	O
(	O
relative	O
weight	O
of	O
0.15	O
)	O
.	O

Treatment	O
type	O
and	O
risk	O
of	O
recurrence	O
were	O
the	O
most	O
important	O
attributes	O
from	O
the	O
conjoint	O
experiment	I:C0681814
(	O
each	O
with	O
a	O
relative	O
weight	O
of	O
0.23	O
)	O
,	O
followed	O
by	O
provider	O
volume	O
(	O
relative	O
weight	O
of	O
0.21	O
)	O
,	O
risk	O
of	O
major	O
complications	B:C0009566
(	O
relative	O
weight	O
of	O
0.18	O
)	O
,	O
and	O
distance	O
needed	O
to	O
travel	O
for	O
treatment	O
(	O
relative	O
weight	O
of	O
0.15	O
)	O
.	O

Treatment	O
type	O
and	O
risk	O
of	O
recurrence	O
were	O
the	O
most	O
important	O
attributes	O
from	O
the	O
conjoint	O
experiment	I:C0681814
(	O
each	O
with	O
a	O
relative	O
weight	O
of	O
0.23	O
)	O
,	O
followed	O
by	O
provider	O
volume	O
(	O
relative	O
weight	O
of	O
0.21	O
)	O
,	O
risk	O
of	O
major	O
complications	O
(	O
relative	O
weight	O
of	O
0.18	O
)	O
,	O
and	O
distance	O
needed	O
to	O
travel	O
for	O
treatment	B:C0087111
(	O
relative	O
weight	O
of	O
0.15	O
)	O
.	O

Procedural	B:C0087111
and	O
treatment	O
preferences	O
did	O
not	O
vary	O
with	O
demographics	O
,	O
self	O
-	I:C2700446
reported	I:C2700446
health	O
status	O
,	O
or	O
familiarity	O
with	O
the	O
procedures	O
.	O

Procedural	O
and	O
treatment	B:C0087111
preferences	O
did	O
not	O
vary	O
with	O
demographics	O
,	O
self	O
-	I:C2700446
reported	I:C2700446
health	O
status	O
,	O
or	O
familiarity	O
with	O
the	O
procedures	O
.	O

Procedural	O
and	O
treatment	O
preferences	O
did	O
not	O
vary	O
with	O
demographics	O
,	O
self	B:C2700446
-	I:C2700446
reported	I:C2700446
health	O
status	O
,	O
or	O
familiarity	O
with	O
the	O
procedures	O
.	O

Procedural	O
and	O
treatment	O
preferences	O
did	O
not	O
vary	O
with	O
demographics	O
,	O
self	O
-	I:C2700446
reported	I:C2700446
health	O
status	O
,	O
or	O
familiarity	B:C0600269
with	O
the	O
procedures	O
.	O

Procedural	O
and	O
treatment	O
preferences	O
did	O
not	O
vary	O
with	O
demographics	O
,	O
self	O
-	I:C2700446
reported	I:C2700446
health	O
status	O
,	O
or	O
familiarity	O
with	O
the	O
procedures	B:C0087111
.	O

Survey	B:C0038951
respondents	O
preferred	O
minimally	O
invasive	O
operations	I:C4048276
over	O
stereotactic	O
body	I:C3896609
radiation	I:C3896609
therapy	I:C3896609
or	O
thoracotomy	O
for	O
treatment	O
of	O
early	O
-	O
stage	O
non	O
-small	I:C0007131
cell	I:C0007131
lung	I:C0007131
cancer	I:C0007131
.	O

Survey	O
respondents	B:C0282122
preferred	O
minimally	O
invasive	O
operations	I:C4048276
over	O
stereotactic	O
body	I:C3896609
radiation	I:C3896609
therapy	I:C3896609
or	O
thoracotomy	O
for	O
treatment	O
of	O
early	O
-	O
stage	O
non	O
-small	I:C0007131
cell	I:C0007131
lung	I:C0007131
cancer	I:C0007131
.	O

Survey	O
respondents	O
preferred	O
minimally	O
invasive	B:C4048276
operations	I:C4048276
over	O
stereotactic	O
body	I:C3896609
radiation	I:C3896609
therapy	I:C3896609
or	O
thoracotomy	O
for	O
treatment	O
of	O
early	O
-	O
stage	O
non	O
-small	I:C0007131
cell	I:C0007131
lung	I:C0007131
cancer	I:C0007131
.	O

Survey	O
respondents	O
preferred	O
minimally	O
invasive	O
operations	I:C4048276
over	O
stereotactic	B:C3896609
body	I:C3896609
radiation	I:C3896609
therapy	I:C3896609
or	O
thoracotomy	O
for	O
treatment	O
of	O
early	O
-	O
stage	O
non	O
-small	I:C0007131
cell	I:C0007131
lung	I:C0007131
cancer	I:C0007131
.	O

Survey	O
respondents	O
preferred	O
minimally	O
invasive	O
operations	I:C4048276
over	O
stereotactic	O
body	I:C3896609
radiation	I:C3896609
therapy	I:C3896609
or	O
thoracotomy	B:C0039991
for	O
treatment	O
of	O
early	O
-	O
stage	O
non	O
-small	I:C0007131
cell	I:C0007131
lung	I:C0007131
cancer	I:C0007131
.	O

Survey	O
respondents	O
preferred	O
minimally	O
invasive	O
operations	I:C4048276
over	O
stereotactic	O
body	I:C3896609
radiation	I:C3896609
therapy	I:C3896609
or	O
thoracotomy	O
for	O
treatment	B:C0087111
of	O
early	O
-	O
stage	O
non	O
-small	I:C0007131
cell	I:C0007131
lung	I:C0007131
cancer	I:C0007131
.	O

Survey	O
respondents	O
preferred	O
minimally	O
invasive	O
operations	I:C4048276
over	O
stereotactic	O
body	I:C3896609
radiation	I:C3896609
therapy	I:C3896609
or	O
thoracotomy	O
for	O
treatment	O
of	O
early	O
-	O
stage	O
non	B:C0007131
-small	I:C0007131
cell	I:C0007131
lung	I:C0007131
cancer	I:C0007131
.	O

Treatment	B:C0087111
modality	O
and	O
risk	O
of	O
cancer	O
recurrence	O
were	O
the	O
most	O
important	O
factors	O
associated	O
with	O
treatment	O
preferences	O
.	O

Treatment	O
modality	O
and	O
risk	O
of	O
cancer	O
recurrence	O
were	O
the	O
most	O
important	O
factors	O
associated	O
with	O
treatment	B:C0087111
preferences	O
.	O

Provider	B:C0031831
experience	O
outweighed	O
the	O
potential	O
need	O
to	O
travel	O
for	O
lung	O
cancer	I:C0242379
treatment	O
.	O

Provider	O
experience	B:C0596545
outweighed	O
the	O
potential	O
need	O
to	O
travel	O
for	O
lung	O
cancer	I:C0242379
treatment	O
.	O

Provider	O
experience	O
outweighed	O
the	O
potential	O
need	O
to	O
travel	O
for	O
lung	B:C0242379
cancer	I:C0242379
treatment	O
.	O

Provider	O
experience	O
outweighed	O
the	O
potential	O
need	O
to	O
travel	O
for	O
lung	O
cancer	I:C0242379
treatment	B:C0087111
.	O

